Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Cancer Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

41 recruiting trials for Cancer. Eligibility criteria explained in plain English.

TrialFinderData lists 41 Cancer clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 36% (5 studies); the largest phase groups are Phase 2: 5, Phase 1 / Phase 2: 4, Phase 1: 3, Phase 2 / Phase 3: 1.

Research is led by Children's Hospital of Philadelphia (3), A2 Biotherapeutics Inc. (2), Population Health Research Institute (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is FOG-001 (drug, 2 trials), followed by Nivolumab, Bevacizumab.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
41
Total Trials
41
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Cancer trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04981119

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Objective: To collect information on how often a solid tumor cancer might lose the Human Leukocyte Antigen (HLA) by next generation sequencing and perform apheresis to collect...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 20016 locations
RECRUITINGNCT03225586

Prospective Urban Rural Epidemiology Study

To examine the impact of health determinants at the individual (e.g. health related behaviors) and societal level (e.g. environmental factors, health related policy, quality of...

Sponsor: Population Health Research InstituteEnrolling: 20000020 locations
RECRUITINGPhase 1NCT06835569

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

The purpose of this study is to characterize the safety and tolerability of ALTA3263 in adults with advanced solid tumors with KRAS mutations.

Sponsor: Alterome Therapeutics, Inc.Enrolling: 44812 locations
RECRUITINGPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors.

Sponsor: Parabilis Medicines, Inc.Enrolling: 59520 locations
RECRUITINGNCT03787056

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Progastrin is a pro-hormone that, in physiological conditions, is maturated in gastrin in G cells of the stomach. The role of the gastrin is to stimulate the secretion of gastric...

Sponsor: Hospices Civils de LyonEnrolling: 41017 locations
RECRUITINGNCT07463833

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 2071 location
RECRUITINGNCT02869802

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

Researchers are looking for better ways of understanding and treating pancreatic cancer. The purpose of this study is to see how useful it is to look for changes and...

Sponsor: British Columbia Cancer AgencyEnrolling: 1904 locations
RECRUITINGNCT06731998

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

This is a research study to evaluate the effectiveness of 3 different types of routine pain management regimens used during clinically indicated, minimally invasive oncologic...

Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Enrolling: 481 location
RECRUITINGNCT01558544

Cryopreservation of Ovarian Tissue

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 3001 location
RECRUITINGPhase 1 / Phase 2NCT03686124

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

The study's purpose is to establish the safety and tolerability of IMA203/IMA203CD8 products with or without combination with nivolumab in patients with solid tumors that express...

Sponsor: Immatics US, Inc.Enrolling: 37520 locations
RECRUITINGNCT05645510

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take...

Sponsor: University of AlbertaEnrolling: 751 location
RECRUITINGNCT02333604

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

The Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis. The Registry is a web-based platform to...

Sponsor: Cancer Support Community, Research and Training Institute, PhiladelphiaEnrolling: 150001 location
RECRUITINGPhase 2 / Phase 3NCT05770102

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With...

This clinical trial is looking at a drug called atezolizumab. Atezolizumab is approved as standard of care treatment for adult patients with urothelial cancer, non-small cell lung...

Sponsor: Cancer Research UKEnrolling: 3020 locations
RECRUITINGPhase 1NCT07317505

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

The goal of this clinical trial is to test JMT108, a type of drug called a bispecific antibody in adult patients with locally advanced or metastatic solid tumors. The main...

Sponsor: Conjupro Biotherapeutics, Inc.Enrolling: 2703 locations
RECRUITINGNCT07327489

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

This study will collect tumor specimens with correlated clinical and demographic data from patients who are undergoing a biopsy or similar procedure to obtain tumor tissue as a...

Sponsor: ElephasEnrolling: 20008 locations
RECRUITINGNCT06892158

Massage Impact on Sleep in Pediatric Oncology

This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 702 locations
RECRUITINGNCT07006155

Biograph Vision 600 Versus Biograph Vision.X PET/CT

The main purpose is to evaluate initial clinical experiences and to explore whether the Vision.X system yields improved image quality and diagnostic performance compared to Vision...

Sponsor: Valentina GaribottoEnrolling: 401 location
RECRUITINGPhase 2NCT04343157

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Brain Metastases

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical...

Sponsor: Jona Hattangadi-GluthEnrolling: 601 location
RECRUITINGNCT07186556

Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of...

The goal of this research study is to learn about the effects of the RISE-YA intervention on cancer-related fatigue in young adults who are brain cancer survivors.

Sponsor: M.D. Anderson Cancer CenterEnrolling: 751 location
RECRUITINGPhase 1 / Phase 2NCT06311851

Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases

Trans arterial chemoembolization (TACE) has emerged as a treatment option for chemotherapy-refractory diseases in Liver metastases. By delivering chemotherapy agents directly to...

Sponsor: Pardis Noor Medical Imaging and Cancer CenterEnrolling: 401 location
RECRUITINGNCT05931068

Perioperative Energy Expenditure in Major Liver Resection

Rationale: Complication rates after major liver resections remain as high as 43%. Many initiatives have been taken to reduce postoperative morbidity. As such, prehabilitation...

Sponsor: Academisch Ziekenhuis MaastrichtEnrolling: 201 location
RECRUITINGNCT04706481

Archival of Human Biological Samples in CU-Med Biobank

CU-Med Biobank collaborates with different researchers for collecting and distributing human biospecimens and clinical data for assisting scientific research.

Sponsor: Chinese University of Hong KongEnrolling: 100001 location
RECRUITINGNCT05398783

A Natural History Study of Metabolic Sizing in Health and Disease

Background: Scientists have long used simple measures (such as height and weight) to estimate how much a person s body uses food (calories) as energy, as commonly called the...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 20001 location
RECRUITINGNCT05248412

The Long-term Spill-over Impact of COVID-19 on Health and Healthcare of People With Non-communicable Diseases

Objectives and aim: To evaluate the long-term spill-over (indirect) effect of Coronavirus disease (COVID-19) on health outcomes and healthcare utilization among people with...

Sponsor: The University of Hong KongEnrolling: 2500001 location
RECRUITINGPhase 2NCT05783323

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 135 locations
RECRUITINGPhase 2NCT06458036

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical...

Sponsor: Children's Hospital of PhiladelphiaEnrolling: 134 locations
RECRUITINGNCT06236373

The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia

This qualitative study seeks to explore the unmet needs of individuals who have recently undergone a cancer diagnosis and completed the acute phase of treatment. The primary...

Sponsor: University of Modena and Reggio EmiliaEnrolling: 451 location
RECRUITINGNCT04615988

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 171 location
RECRUITINGNCT05347524

Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective Study

This study is a prospective, multi-omics, observational study aimed at detecting peritoneal metastasis of gastric cancer by combined assays for methylation of cell-free DNA...

Sponsor: Shanghai Zhongshan HospitalEnrolling: 3841 location
RECRUITINGPhase 2NCT04673942

A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors

AdAPT-001 is an oncolytic virus that is injected directly into the tumor or via intraarterial administration. The purpose of this study is to find out if AdAPT-001 is safe and...

Sponsor: EpicentRx, Inc.Enrolling: 1406 locations
RECRUITINGPhase 1NCT06440005

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an...

Sponsor: Angiex, Inc.Enrolling: 806 locations
RECRUITINGPhase 2NCT06790082

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

Seventy (N=70) patients with suspected pleural mesothelioma (PM) lesions referred to pleural biopsy will be recruited, and undergo an additional FAPI PET/CT at primary staging....

Sponsor: Aalborg University HospitalEnrolling: 701 location
RECRUITINGPhase 1 / Phase 2NCT06051695

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid...

The goal of this study is to test autologous logic-gated Tmod™ CAR T-cell products in subjects with solid tumors including colorectal cancer (CRC), pancreatic cancer (PANC),...

Sponsor: A2 Biotherapeutics Inc.Enrolling: 47412 locations
RECRUITINGNCT06313853

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a...

Building upon prior work, the investigator team developed a communication intervention for older adults with ADRD who are considering a decision about cancer management (adapted...

Sponsor: University of RochesterEnrolling: 3001 location
RECRUITINGNCT04696081

Atrial Fibrillation in Active Cancer Patients

Atrial fibrillation is a common complication of both cancer and anticancer drugs but the consequences of such events remain poorly known and are not adressed in both phase III...

Sponsor: University Hospital, CaenEnrolling: 10001 location
RECRUITINGPhase 4NCT06603870

Secondary Prevention of VTE in Patients With Cancer and Catheter-Related Upper Extremity Deep Vein Thrombosis

This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and catheter-related...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 3301 location
RECRUITINGNCT06451003

Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery

While blood clots after major cancer surgery are common and harmful to patients, the medications to decrease blood clot risk are seldom used after patients leave the hospital...

Sponsor: Medical University of South CarolinaEnrolling: 301 location
RECRUITINGNCT06944262

Assessment of Cancer-related Post-traumatic Stress in Patients and Caregivers in the Year Following Diagnosis, and...

The impact of cancer on the lives of patients and their caregivers is undeniable. In addition to the potentially traumatic aspects (i.e., creating a very violent emotional shock)...

Sponsor: Lille UniversityEnrolling: 3502 locations
RECRUITINGNCT04741906

Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

Aim of the study is to examine the feasibility of dental implant insertion in patients receiving high, adjuvant and low dose \> 4 years.

Sponsor: Copenhagen University Hospital at HerlevEnrolling: 2251 location
RECRUITINGNCT07518446

Somatic Health Screening for Adults in Outpatient Psychiatric Care in Denmark (SomaScreen)

People with severe mental illness have a substantially increased risk of undiagnosed and insufficiently treated somatic disease. Somatic Screening in the Capital Region Mental...

Sponsor: Amager HospitalEnrolling: 28001 location
RECRUITINGNCT06752512

Remote Temperature Monitoring of Patients At Risk for Developing Fever

The purpose of this program is to evaluate remote temperature monitoring in cancer patients at risk of fever and infection due to chemotherapy treatment. The main questions it...

Sponsor: AION BiosystemsEnrolling: 1501 location

Frequently Asked Questions

There are currently 41 clinical trials for Cancer, with 41 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Cancer, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cancer, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.